Skip to main content

Exercise of warrants

Information regarding exercise of warrants of series 2023:1 in Moberg Pharma AB

The Board of Directors of Moberg Pharma resolved on June 28, 2023, with the approval of the Extraordinary General Meeting on August 8, 2023, to carry out a new issue of ordinary shares and warrants ("Units") of approximately SEK 100 million with preferential rights for existing shareholders (the "Rights Issue"). On September 1, 2024, the outcome of the Rights Issue was announced, where the Rights Issue was oversubscribed and all Units under the Rights Issue were issued. Each Unit consisted of one ordinary share and one warrant of series 2023:1 ("warrant" or "TO 2") free of charge.

The warrants were issued free of charge and can be exercised for subscription of new shares during the period 5 June - 19 June 2024. A total of 18,134,519 warrants were issued, where one warrant entitles the holder to subscribe for one new ordinary share in Moberg Pharma. The last day for trading in warrants of series 2023:1 is June 17, 2024. In order for your warrants not to expire worthless, it is required that you subscribe for new ordinary shares in Moberg Pharma, by exercising your warrants, no later than June 19, 2024, or alternatively sell your warrants on Nasdaq Stockholm no later than June 17, 2024.

Terms in brief

  • One warrant entitles you to subscribe for one ordinary share in Moberg Pharma during the period June 5 - June 19, 2024.
  • The subscription price is 70 percent of the volume-weighted average price paid for Moberg Pharma's ordinary share during the period from May 20, 2024 up to and including May 31, 2024, but not less than the quota value of Moberg Pharma's share. The subscription price to be announced in the evening of May 31, 2024.
  • The warrants have ISIN code SE0020678944 and are subject to trading on Nasdaq Stockholm.
  • The last day of trading in warrants is June 17, 2024.

Complete terms and conditions regarding the warrants and information about Moberg Pharma are available in the prospectus approved by the Swedish Financial Supervisory Authority and published by the Company on August 14, 2023.

Download related documents:

Prospectus (only available in Swedish)
Full terms and conditions (only available in Swedish)
The company´s latest quarterly report. The next quarterly report will be published on May 7.
Application forms will be posted on May 31.

Trading in warrants:
Link to Moberg TO 2 via Avanza
Link to Moberg TO 2 via Nordnet

Trading in shares:
Link to Moberg share via Avanza
Link to Moberg share via Nordnet

If your warrants are nominee registered

Subscription and payment of new shares, through exercise of warrants, shall be made to the respective bank or other nominee where the warrants are registered. Subscription and payment shall be made in accordance with the instructions provided by each such bank or nominee. Usually the bank/trustee will send a digital notice to the account holder, otherwise it is usually sufficient to log in to the securities depository from the first day of the exercise period to receive instructions on how to exercise warrants to subscribe for new shares. Please contact your bank or nominee if you cannot find these instructions. Note that banks and other trustees may set different time limits for subscription, therefore it is recommended that you contact your bank/trustee early in the exercise period to obtain information on subscription and payment. Subscribed and paid shares may be registered at your securities depository as "interim shares" or "IA" until the registration of the new shares is completed at the Swedish Companies Registration Office, whereupon interim shares are automatically converted into ordinary shares in Moberg Pharma.

If your warrants are directly registered

Application is made via an application form available on Vator Securities and Moberg Pharma's respective websites. Payment is made according to the instructions on the application form. Both application form and payment must be received by Vator Securities no later than 15.00 on 19 June 2024. Subscribed and paid shares will be registered on your VP account as "interim shares" ("IA") until the registration of the new shares is completed at the Swedish Companies Registration Office, whereupon interim shares will automatically be converted into ordinary shares in Moberg Pharma.

Note that the warrants series that are not exercised no later than June 19, 2024, or disposed of no later than June 17, 2024, expire worthless. In order for the warrants not to expire, active subscription of shares or disposal of warrants is required. Please note that some nominees may close their application earlier than June 19, 2024.

Important dates for warrants of series 2023:1

PLEASE NOTE - In order for your warrants not to expire worthless, you are required to actively subscribe and pay for shares no later than June 19, 2024, or dispose of your warrants no later than June 17, 2024.

May 20 - May 31, 2024: Determination of the subscription price based on the Volume Weighted Average Price (VWAP) for Moberg Pharma's ordinary share - 70 percent of the volume weighted average price paid for Moberg Pharma's ordinary share during the period from May 20, 2024 up to and including May 31, 2024, but no less than the quota value of Moberg Pharma's share. The subscription price will be announced in the evening of May 31, 2024.

June 5, 2024: The exercise period begins

June 17, 2024: Last day for trading in warrants

June 19, 2024: Exercise period ends

June 24, 2024: Planned date for publication of exercise rate

Around July 5, 2024: Planned date for conversion of interim shares to shares

Q & A

  1. What does the warrant mean?

One warrant gives the right (but not the obligation) to subscribe for one new ordinary share in Moberg Pharma during the period June 5 - 19, 2024.

  1. What do I pay for a new ordinary share if I have a warrant?

70 percent of the volume-weighted average price paid for Moberg Pharma's ordinary share during the period from and including May 20, 2024 to and including May 31, 2024, but not less than the quota value of Moberg Pharma's share. The subscription price will be announced in the evening of May 31, 2024.

  1. Is it possible to trade the warrants?

Yes, since September 20, 2023 the warrants (Moberg TO 2) are traded on Nasdaq Stockholm. The warrants have ISIN code: SE0020678944. The last day of trading in the warrants is June 17, 2024.

  1. How many warrants are there?

There are 18,134,519 outstanding warrants.

  1. What is the last day to sell warrants so that they do not expire worthless?

The last day to trade the warrants is June 17, 2024.

  1. When is the last date for subscription of shares by virtue of warrants?

Both the application form and payment must be received by Vator Securities no later than 15.00 on June 19, 2024. Note that banks and other managers may set different time limits for subscription, so it is recommended that you contact your bank/manager early in the exercise period to obtain information about subscription and payment.

  1. Where can I find more information?

Further information is available in the Prospectus from August 14, 2023 Read here Full terms and conditions of the options Read here.

  1. What do I do if I am resident outside Sweden?

Professional and institutional investors who are resident outside Sweden and who do not have the opportunity to purchase warrants on Nasdaq Stockholm can, under certain conditions, still acquire and exercise them. For questions and information on how warrants can be used, please contact Vator Securities by phone at +46 8-5800 65 912 or by e-mail at emissioner@vatorsec.se.